EPIDIOLEX

Project Date: 2018 - 2019

The first and only FDA-approved prescription cannabidiol (CBD) to treat seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome, or tuberous sclerosis complex (TSC) in patients 1 year of age or older.

Client

Greenwich Biosciences

NY Creative Lead

Type of Work

Campaign Refresh

Branding

PH Creative Lead

Took the EPIDIOLEX narrative and shaped it into a cohesive, visually compelling campaign.

Led concept development, design, and strategy across all materials, creating a brand experience that feels clear, consistent, and engaging.